261 related articles for article (PubMed ID: 29916899)
21. Down-regulation of MALAT1 inhibits cervical cancer cell invasion and metastasis by inhibition of epithelial-mesenchymal transition.
Sun R; Qin C; Jiang B; Fang S; Pan X; Peng L; Liu Z; Li W; Li Y; Li G
Mol Biosyst; 2016 Mar; 12(3):952-62. PubMed ID: 26798987
[TBL] [Abstract][Full Text] [Related]
22. Dexmedetomidine inhibits the growth and metastasis of esophageal cancer cells by down-regulation of lncRNA MALAT1.
Zhang W; Zhang L; Cai XJ; Li D; Cao FJ; Zuo ZG; Song Y; Yu XJ; Liu S
Kaohsiung J Med Sci; 2022 Jun; 38(6):585-593. PubMed ID: 35199933
[TBL] [Abstract][Full Text] [Related]
23. LncRNA MALAT1 promotes colorectal cancer development by sponging miR-363-3p to regulate EZH2 expression.
Xie JJ; Li WH; Li X; Ye W; Shao CF
J Biol Regul Homeost Agents; 2019; 33(2):331-343. PubMed ID: 30972996
[TBL] [Abstract][Full Text] [Related]
24. The long non-coding RNA DANCR regulates the inflammatory phenotype of breast cancer cells and promotes breast cancer progression via EZH2-dependent suppression of SOCS3 transcription.
Zhang KJ; Tan XL; Guo L
Mol Oncol; 2020 Feb; 14(2):309-328. PubMed ID: 31860165
[TBL] [Abstract][Full Text] [Related]
25. LncRNA PCAT1 promotes metastasis of endometrial carcinoma through epigenetical downregulation of E-cadherin associated with methyltransferase EZH2.
Zhang C; Shao S; Zhang Y; Wang L; Liu J; Fang F; Li P; Wang B
Life Sci; 2020 Feb; 243():117295. PubMed ID: 31927050
[TBL] [Abstract][Full Text] [Related]
26. Repression of PDK1- and LncRNA HOTAIR-Mediated EZH2 Gene Expression Contributes to the Enhancement of Atractylenolide 1 and Erlotinib in the Inhibition of Human Lung Cancer Cells.
Xiao Q; Zheng F; Tang Q; Wu JJ; Xie J; Huang HD; Yang XB; Hann SS
Cell Physiol Biochem; 2018; 49(4):1615-1632. PubMed ID: 30223276
[TBL] [Abstract][Full Text] [Related]
27. MALAT1 predicts poor survival in osteosarcoma patients and promotes cell metastasis through associating with EZH2.
Huo Y; Li Q; Wang X; Jiao X; Zheng J; Li Z; Pan X
Oncotarget; 2017 Jul; 8(29):46993-47006. PubMed ID: 28388584
[TBL] [Abstract][Full Text] [Related]
28. LncRNA-MEG3 inhibits cell proliferation of endometrial carcinoma by repressing Notch signaling.
Guo Q; Qian Z; Yan D; Li L; Huang L
Biomed Pharmacother; 2016 Aug; 82():589-94. PubMed ID: 27470401
[TBL] [Abstract][Full Text] [Related]
29. LncRNA MALAT1 enhances oncogenic activities of EZH2 in castration-resistant prostate cancer.
Wang D; Ding L; Wang L; Zhao Y; Sun Z; Karnes RJ; Zhang J; Huang H
Oncotarget; 2015 Dec; 6(38):41045-55. PubMed ID: 26516927
[TBL] [Abstract][Full Text] [Related]
30. HOTAIR-mediated reciprocal regulation of EZH2 and DNMT1 contribute to polyphyllin I-inhibited growth of castration-resistant prostate cancer cells in vitro and in vivo.
Xiang S; Zou P; Tang Q; Zheng F; Wu J; Chen Z; Hann SS
Biochim Biophys Acta Gen Subj; 2018 Mar; 1862(3):589-599. PubMed ID: 29221985
[TBL] [Abstract][Full Text] [Related]
31. Notch-1-mediated esophageal carcinoma EC-9706 cell invasion and metastasis by inducing epithelial-mesenchymal transition through Snail.
Wang T; Xuan X; Pian L; Gao P; Hu H; Zheng Y; Zang W; Zhao G
Tumour Biol; 2014 Feb; 35(2):1193-201. PubMed ID: 24022665
[TBL] [Abstract][Full Text] [Related]
32. Long noncoding RNA SNHG6 silencing sensitized esophageal cancer cells to 5-FU via EZH2/STAT pathway.
Tan R; Liu J; Wang J; Zhang W; He M; Zhang Y
Sci Rep; 2023 Apr; 13(1):5363. PubMed ID: 37005451
[TBL] [Abstract][Full Text] [Related]
33. MALAT1 long ncRNA promotes gastric cancer metastasis by suppressing PCDH10.
Qi Y; Ooi HS; Wu J; Chen J; Zhang X; Tan S; Yu Q; Li YY; Kang Y; Li H; Xiong Z; Zhu T; Liu B; Shao Z; Zhao X
Oncotarget; 2016 Mar; 7(11):12693-703. PubMed ID: 26871474
[TBL] [Abstract][Full Text] [Related]
34. Effect of long non-coding RNA PVT1 on cell proliferation and migration in melanoma.
Chen L; Ma D; Li Y; Li X; Zhao L; Zhang J; Song Y
Int J Mol Med; 2018 Mar; 41(3):1275-1282. PubMed ID: 29286144
[TBL] [Abstract][Full Text] [Related]
35. Long Non Coding RNA MALAT1 Promotes Tumor Growth and Metastasis by inducing Epithelial-Mesenchymal Transition in Oral Squamous Cell Carcinoma.
Zhou X; Liu S; Cai G; Kong L; Zhang T; Ren Y; Wu Y; Mei M; Zhang L; Wang X
Sci Rep; 2015 Nov; 5():15972. PubMed ID: 26522444
[TBL] [Abstract][Full Text] [Related]
36. Up-regulation of lncRNA CASC9 promotes esophageal squamous cell carcinoma growth by negatively regulating PDCD4 expression through EZH2.
Wu Y; Hu L; Liang Y; Li J; Wang K; Chen X; Meng H; Guan X; Yang K; Bai Y
Mol Cancer; 2017 Aug; 16(1):150. PubMed ID: 28854977
[TBL] [Abstract][Full Text] [Related]
37. Ulinastatin protects against lipopolysaccharide-induced cardiac microvascular endothelial cell dysfunction via downregulation of lncRNA MALAT1 and EZH2 in sepsis.
Yu Z; Rayile A; Zhang X; Li Y; Zhao Q
Int J Mol Med; 2017 May; 39(5):1269-1276. PubMed ID: 28405676
[TBL] [Abstract][Full Text] [Related]
38. EZH2 regulates oncomiR-200c and EMT markers in esophageal squamous cell carcinomas.
Nourmohammadi F; Forghanifard MM; Abbaszadegan MR; Zarrinpour V
Sci Rep; 2022 Oct; 12(1):18290. PubMed ID: 36316365
[TBL] [Abstract][Full Text] [Related]
39. Long non-coding RNA MINCR promotes gallbladder cancer progression through stimulating EZH2 expression.
Wang SH; Yang Y; Wu XC; Zhang MD; Weng MZ; Zhou D; Wang JD; Quan ZW
Cancer Lett; 2016 Sep; 380(1):122-33. PubMed ID: 27345740
[TBL] [Abstract][Full Text] [Related]
40. The degradation of EZH2 mediated by lncRNA ANCR attenuated the invasion and metastasis of breast cancer.
Li Z; Hou P; Fan D; Dong M; Ma M; Li H; Yao R; Li Y; Wang G; Geng P; Mihretab A; Liu D; Zhang Y; Huang B; Lu J
Cell Death Differ; 2017 Jan; 24(1):59-71. PubMed ID: 27716745
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
